Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

Pharmaceutical CRO and CDMO Companies, Market Entry and Expansion Strategies

Date : 11 February 2026

Meet the Top Companies of the Pharmaceutical CRO and CDMO Market and Explore their Company Profile

Pharmaceutical CRO and CDMO Market Key Players

Company Profile

Pharmaceutical CRO and CDMO Headquarters Services
IQVIA North Carolina, U.S. Phase 1-4 clinical trials and advanced technologies
ICON plc Dublin, Ireland Full-service clinical development, biosimilar research, and adaptive trial designs
Parexel Massachusetts, U.S. Phase 1-4 clinical development, AI-driven trial simulation, and post-market surveillance
Charles River Laboratories Massachusetts, U.S. Preclinical discovery, laboratory models, efficacy testing ad safety assessment
Medpace Ohio, U.S. Integrated full-service clinic trials and central laboratory services
Lonza Group Basel, Switzerland Biologic manufacturing, API synthesis, and cell and gene therapy development.
Samsung Biologics Incheon, South Korea Large-scale biologics manufacturing, small molecule substances, drug product filling, and monoclonal antibodies production
Catalent New Jersey, U.S. Oral, respiratory drug delivery technologies, cell and gene therapy manufacturing
Boehringer Ingelheim Ingelheim, Germany Contract manufacturing for biologics, small molecule chemical innovation, and process development
Thermo Fisher Scientific Massachusetts, U.S. End-to-end solutions, API manufacturing, sterile fill-finish, and clinical trials logistics

Market Value Chain Analysis

R&D

  • The R&D of the pharmaceutical CRO and CDMO focuses on enhancing drug discovery and optimizing their manufacturing using advanced platforms and AI-driven solutions.
  • Key players: IQVIA, WuXi AppTec, Lonza.

Clinical Trials and Regulatory Approvals

  • The drug safety, quality, efficacy, and manufacturing compliance are evaluated in the clinical trials and regulatory approvals of the pharmaceutical CRO and CDMO.
  • Key players: ICON plc, Lonza, Catalent.

Formulation and Final Dosage Preparation

  • The formulation and final dosage preparation in the pharmaceutical CRO and CDMO focus on the development of various formulations ranging from oral solids to sterile injectables by optimizing drug stability and delivery mechanisms.
  • Key players: Lonza, Catalent, Patheon.

Packaging and Serialization

  • The packaging and serialization of pharmaceutical CRO and CDMO products involves the use of tamper-evident designs and unique data track barcodes to maintain product integrity and supply chain traceability.
  • Key players: Thermo Fisher Scientific, Catalent, PCI Pharma Services.

Patient Support and Services

  • Decentralized trials platform, digital engagement tools, and home nursing are provided in the patient support and services of the pharmaceutical CRO and CDMOs.
  • Key players: IQVIA, ICON plc, Parexel.

Market Growth

The global pharmaceutical CRO and CDMO market size was estimated at USD 254.65 billion in 2025 and is predicted to increase from USD 277.16 billion in 2026 to approximately USD 594.07 billion by 2035, expanding at a CAGR of 8.84% from 2026 to 2035.

Pharmaceutical CRO and CDMO Market Trends and Growth (2026)

Recent Developments in the Market

  • In January 2026, a collaboration was formed between ST Pharm, which is a Korean CDMO, and a U.S.-based biotech company, where they will develop an oligonucleotide-based treatment for patients suffering from severe hypertriglyceridemia.
  • In March 2025, a 'hybrid' CDMO model was launched by Shilpa Medicare, which is an Indian CDMO at DCAT 2025, where the company will offer traditional CDMO services and ready-to-license novel formulations.

Get complete Pharmaceutical CRO and CDMO Market data and deep insights under a single roof: Access the Dashboard

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales